0 CHECKOUT

PRODUCT FILTERS

REGION

2,185
1,423
1,420
1,330
1,330

COUNTRY

1,315
148
89
87
86

CATEGORIES

  • 333
  • 318
  • 252
  • 247
  • 211
  • 190
  • 186
  • 150
  • 149
  • 138
  • 134
  • 134
  • 102
  • 100
  • 43

PRICE

611
1,198
2,181
4,793

PUBLISHED

311
1,299
2,602
4,793

PRODUCT TYPE

3,952
361
256
170
51
2
1

Oncology Drugs Market Research Reports

The American Cancer Society forecasts that 1,638,910 new cancer cases will occur in the United States in 2012. As cancer rates worldwide are increasing, the oncological sector of the pharmaceutical industry is growing fast and it will continue to provide business opportunities in the next years. However, cancer trials are some of the most complex, time consuming and expensive across all therapeutic areas. What are the new paths to success in this lucrative but challenging market?

Find out the answer in the reports, books, and subscriptions listed under Research and Markets’ Oncology category. Our top-quality publications from industry experts cover every aspect of cancer drug therapy, with a focus on: Lung Cancer, Breast Cancer, Prostate Cancer, Leukaemia, Lymphoma, Ovarian Cancer, Colon Cancer, Cervical Cancer, Brain Cancer and Bladder Cancer. So read on for the latest clinical trials, pipeline reviews, industry news, and commercial opportunities.

Key players featured in our publications include Abbott, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Johnson & Johnson, Merck, Novartis, Pfizer, Roche, Sanofi-Aventis, Wyeth, and many more. Show Less
Read more

Sunitinib Malate Market Forecast for Pancreatic Cancer in G7 Countries, (U.S., Germany, France, U.K., Italy, Spain, Japan) - 2016 to 2017

The sunitinib malate market for pancreatic cancer is projected to reach USD 76.7 million by 2021, at a CAGR of 13.9% from 2016 to 2021. The growing incidence of pancreatic cancer (especially pNET) and...

Published:  May 2016
Price:  From

Prostate Cancer Therapeutics - Global Strategic Business Report

The report provides separate comprehensive analytics for the US, Canada, Europe, and Rest of World. Annual estimates and forecasts are provided for the period 2015 through 2022. Also, a six-year historic...

Published:  May 2016
Price:  From

Global Infection Control in Cancer Therapy Market Analysis & Trends - Industry Forecast to 2025

This industry report analyzes the global markets for Infection Control in Cancer Therapy across all the given segments on global as well as regional levels presented in the research scope. The study...

Published:  June 2016
Price:  From

Drug Delivery in Cancer - Technologies, Markets and Companies

Drug delivery remains a challenge in management of cancer. Approximately 12.5 million new cases of cancer are being diagnosed worldwide each year and considerable research is in progress for drug discovery...

Published:  June 2016
Price:  From

Global Oncology Ablation Market Outlook: 2015-2020 (2nd Edition)

Oncology Ablation is the minimal invasive treatment that is used to destroy or inactive the cancer cells and tumors. The market for oncology ablation is on the rise due to increasing number of cancer...

Published:  March 2016
Price:  From

Malignant Melanoma Pricing and Reimbursement

With several new high cost melanoma drugs available, payer decisions on whether patients can access those drugs and under what conditions are becoming more important than ever. This report covers both...

Published:  September 2015
Price:  From

Breast Cancer Therapeutics: Pipeline Analysis Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2015 - 2023

The report on breast cancer therapeutics: pipeline analysis market studies the future market of breast cancer drugs on the basis of the molecules which are currently under pipeline. Breast cancer usually...

Published:  August 2015
Price:  From

Ablation Technologies Market by Product (Radiofrequency, Ultrasound, Irreversible Electroporation, Cryotherapy, Microwave) & Application - Global Forecasts to 2020

"Ablation Technologies Market by Product (Radiofrequency, Ultrasound, Irreversible Electroporation, Cryotherapy, Microwave) & Application (Cardiovascular, Cancer, Pain Management, Cosmetic Surgery,...

Published:  February 2016
Price:  From

Oncology Pathways in the US - Friend or Foe for Pharma?

The costs of treating cancer in the US are spiralling upward, and payers have taken notice. This report takes a detailed look at the growing focus on value and quality that is driving greater use of...

Published:  July 2015
Price:  From

Global Cancer Stem Cell Therapy Market Outlook 2020

Investigators discovered stem cells during their quest to find innovative cell therapy methods which could offer edge over prevailing modalities. These cells have ability to divide several times without...

Published:  April 2016
Price:  From

Global Malignant Melanoma Drug Market & Clinical Pipeline Insight

Investigators are trying to develop innovative therapeutics for the treatment of malignant melanoma with high safety and efficacy. Surgery has remained the corner stone of cancer treatment including...

Published:  May 2016
Price:  From

World Castration-Resistant Prostate Cancer (CRPC)/HRPCA Therapeutics - Market Opportunity and Forecast, 2014 - 2020

Castration-Resistant Prostate Cancer (CRPC) or Hormone Refractory Prostate Cancer (CRPC), a type of prostate cancer that typically recurs after administering androgen deprivation therapy (ADT), is gaining...

Published:  July 2015
Price:  From

Immunotherapy Drugs Market by Type of Drug, Epidemiology, Regulatory and Pipeline Analysis - Global Forecast to 2020

In this report, the immunotherapy market is segmented into types of drugs and region. By types of drug, the market is further subsegmented into antibodies, interferons, interleukins, vaccines and checkpoint...

Published:  December 2015
Price:  From

HPAPIs and Cytotoxic Drugs Manufacturing Market (2nd Edition), 2016 - 2026

The ‘HPAPIs and Cytotoxic Drugs Manufacturing Market, 2016-2026 (2nd edition)’ report provides an extensive study of the rapidly growing manufacturing market of HPAPIs and cytotoxic drugs. Due to their...

Published:  March 2016
Price:  From

LAMEA Oncology/Anti-cancer Drugs Market - Opportunities and Forecasts, 2014 - 2021

Oncology/Anti-cancer drugs are used for treating various cancer types for improving and prolonging a patients survival time. Biological drugs, based on monoclonal antibodies (mAbs) would emerge as a...

Published:  February 2016
Price:  From

Cancer Bundle

The Cancer Bundle offers a 15% discount off the total transaction price for the following reports being purchased simultaneously: - Biomarker Technology Platforms for Cancer Diagnoses and Therapies -...

Published:  January 2016
Price:  From

US Blood Cancer Drug Market & Pipeline Analysis 2015

Pharmaceutical companies have identified the opportunities to generate significant revenues from blood cancer segment in US. Escalating blood cancer incidences, high unmet medical necessities and demand...

Published:  July 2015
Price:  From

Cancer CD Antigens Inhibitors Therapy Market & Pipeline Insight 2015

Pharmaceutical companies are continuously looking for better therapeutic options to effectively cure and prevent various malignancies. Several options for cancer treatment are available belonging to...

Published:  August 2015
Price:  From

Global T-Cell Lymphoma Market & Clinical Pipeline Insight

Immune system consists of various cells that impart resistance to body against foreign entities. They also prevent the development of aberrant cells in the body to maintain its normal functioning. However,...

Published:  March 2016
Price:  From

T-Cell Immunotherapy Market, 2015-2030

This report provides an extensive study of the field of T-cell immunotherapy. With no marketed products, this emerging field is still in its infancy; the report provides a comprehensive view of the...

Published:  October 2015
Price:  From
Loading Indicator

Our Clients